建立癌症细胞系和裸鼠已经癌症研究的中流砥柱,在过去的几十年。然而,最近的证据表明,治疗响应在很大程度上是通过肿瘤细胞微环境的影响。因此,我们开发了原发肿瘤标本进行药物开发目的的体外分析。
The molecular analysis of established cancer cell lines has been the mainstay of cancer research for the past several decades. Cell culture provides both direct and rapid analysis of therapeutic sensitivity and resistance. However, recent evidence suggests that therapeutic response is not exclusive to the inherent molecular composition of cancer cells but rather is greatly influenced by the tumor cell microenvironment, a feature that cannot be recapitulated by traditional culturing methods. Even implementation of tumor xenografts, though providing a wealth of information on drug delivery/efficacy, cannot capture the tumor cell/microenvironment crosstalk (i.e., soluble factors) that occurs within human tumors and greatly impacts tumor response. To this extent, we have developed an ex vivo (fresh tissue sectioning) technique which allows for the direct assessment of treatment response for preclinical and clinical therapeutics development. This technique maintains tissue integrity and cellular architecture within the tumor cell/microenvironment context throughout treatment response providing a more precise means to assess drug efficacy.
发展有效的癌症疗法已被证明是极具挑战性的。肿瘤细胞系和肿瘤外植体-以及异种移植物已被用于癌症研究的半个多世纪1,2,3。迄今为止,药物敏感性和抗性均建立肿瘤细胞系和来自患者的异种移植物中的分子分析(PDX)是不可缺少的。然而,在建立的肿瘤细胞系的化合物的检测是不经常的预测在体内的药效,并对应在体内研究中的动物,特别是在PDX模型,是非常昂贵和费时的。这些模型系统,即无法告知的原生微环境中肿瘤进展和应对治疗策略的影响的局限性,导致了研究领域,开发更多的方法来赞美这些分析。近期,高度地注意对病人TUM的体外分析或外植体4,5由于较大的理解是癌的治疗反应是不排斥对癌细胞的内在分子组成,而是由肿瘤细胞微环境6,7一项功能,不能用传统的培养方法和可概括的影响很大/或PDX。 体外分析在上述情况下( 即 ,相邻的周围的肿瘤细胞微环境的影响)意味着可行原发性肿瘤/转移部分的评估,而不是细胞株8,9的体外分析。
我们在这里报告的离体技术( 即 ,精确切片新鲜组织切片)既患者的原发肿瘤和转移相关( 即 ,淋巴结),忠实地通知关于反应(IC 50),脱靶效应,并允许分子分析性和反馈机制。此外,相关therape分析UTIC敏感性/抗性与生物标记物和基因表达图谱可以在努力确定患者更可能对实验药物的兴趣响应来执行( 即 ,高的药物响应相匹配的患者与特定生物信息)。在体外的技术和评估的多参数的方式中的应用是对病人的选择和临床疗效的整体改善运动。
体外治疗反应的分析可以成为癌症治疗的临床前和临床开发的标准工具,并设想为对治疗性发展战略的一个个性化医疗方法的一个步骤。
试图制定有效的治疗策略时,癌症生物学家面临显著挑战。在开发上建立肿瘤细胞系测试药物不能准确地反映体内响应和在上PDX模型体内实验是劳动密集型的并且非常昂贵。鉴于上述情况,原发性患者的体外技术的应用肿瘤14,15现在位于建立肿瘤细胞系和患者来源的异种移植物(PDX)的分子分析的旁边。
本文以体外技术的应用推向?…
The authors have nothing to disclose.
The authors would like to thank the MSKCC Tissue Procurement Service Team (TPS), specifically, Maria Corazon Mariano, Priscilla McNeil, Anas Idelbi, Daniel Navarrete and Katrina Allen, in all of their efforts in the successful pursuit of this project and funding from the following sources: 5 R21 CA158609-02 and the Conquer Cancer Foundation and the Breast Cancer Research Foundation. In addition, the authors would like to thank Eric Cottington PhD, Vice President of the Office of Research and Project Administration, the Office of Technology Development, Research Outreach and Compliance and RTM Information Systems Support, in the support of the submission of this manuscript.
Name of Material/ Equipment | Company | Catalog Number | Comments/Description |
Vibratome Leica VT1000s | Leica | 14047235613 | |
UltraPure agarose | Invitrogen | 16500500 | Prepare 4% and 6% before use |
Injector blade | Ted Pella | 121-4 | |
MEM with Penicillin + Streptomycin | Media Core Facilities (MSKCC) | The media is prepared at Memorial Sloan Kettering Cancer Center | |
Scalpel no. 10 | Thermo Scientific | 31-200-32 | |
Disposable forceps | Cole-Parmer | 84011182 | |
Embedding mold | Electron Microscopy Science | 70181 | |
FBS (heat inactivated) | Gemini | 100106 | |
24 well plates | Corning | 3524 | |
Formalin (10%) | Sigma Diagnostics | SDHT501128 | |
16% Formaldehyde solution | Thermo Scientific | 28908 | |
Embedding microsettes | Simport | M503-2 | |
Ethanol (70%) | Fisher Scientific | A405P-4 | |
Waterbath | Fisher Scientific | 15-462-2SQ | |
Microwave | General Electric | ModelJES2051DNBB | |
Adhesive (Ethyl Cyanoacrylate) | Sigma-Aldrich | E1505-5G | |
10mm dishes | BD Falcon | 353003 | |
15ml tubes | BD Falcon | 352096 |